Make Rheum for PMR Campaign conducted weekly surveys of rheumatologists. This slide set includes survey results and other supportive slides addressing:
- Diagnosis and monitoring
- Steroids in PMR
- Steroid-sparing therapy in PMR
- Controversies in PMR
These are slides of the survey results from 4 weekly surveys conducted in September 2023 - during the "Hard Decisions in RA" Campaign
Each Survey week had a different theme:
A slides set on RA Treatment options with MTX teaching slides
Slide set dedicated to the diagnosis of RA; including serologic testing and pre-clinical RA
The ongoing challenge of information overload and what you can do to manage.
The risk of autoimmunity and rheumatic disease is heightened in women, especially with aging and certain populations
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
